Head-to-head
Found vs LillyDirect (Zepbound)
Compared on tirzepatide across the eight dimensions this database records. They differ on 6 of those eight. Found is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Found is $289 a month all-in for tirzepatide; LillyDirect (Zepbound) is $449. Over twelve months that is $3,468 against $5,388. Value Scores are 68.7 and 46.3 out of 100.
Tirzepatide
Plan pages: Found plans · LillyDirect (Zepbound) plans
At 10 mg/week, Found is $289 a month all-in and LillyDirect (Zepbound) is $449 — $160 apart, or $1,920 across a year. Over twelve months the totals are $3,468 (billed monthly) and $5,388 (billed monthly).
Found charges a flat $289 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
LillyDirect (Zepbound) prices tirzepatide by dose: $299 per month at 2.5 mg rising to $449 at 7.5 mg, a difference of $150 a month between the bottom and top of the ladder.
| Dose | Found | Rank | LillyDirect (Zepbound) | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $289 | 15/31 | $299 | 18/31 | Found by $10 |
| 5 mg | $289 | 8/17 | $399 | 14/17 | Found by $110 |
| 7.5 mg | $289 | 8/17 | $449 | 16/17 | Found by $160 |
| 10 mg | $289 | 10/27 | $449 | 24/27 | Found by $160 |
| 12.5 mg | $289 | 8/17 | $449 | 16/17 | Found by $160 |
| 15 mg | $289 | 8/17 | $449 | 16/17 | Found by $160 |
Found is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Found sits 9 of 27 on all-in monthly cost and LillyDirect (Zepbound) sits 23. There are 13 other programs priced between them. The field median is $339 and the floor is $169, so Found is below the median and the other is above it. Found is $120 above the cheapest tirzepatide program on record. LillyDirect (Zepbound) is $280 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Found undercuts it by $160, LillyDirect (Zepbound) by $0. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Found | LillyDirect (Zepbound) | Cheaper |
|---|---|---|---|
| Month to month | $289 | $449 | Found by $160 |
| Settled dose | Found | LillyDirect (Zepbound) | Difference |
|---|---|---|---|
| 2.5 mg | $3,468 | $3,588 | $120 apart |
| 5 mg | $3,468 | $4,788 | $1,320 apart |
| 7.5 mg | $3,468 | $5,388 | $1,920 apart |
| 10 mg | $3,468 | $5,388 | $1,920 apart |
| 12.5 mg | $3,468 | $5,388 | $1,920 apart |
| 15 mg | $3,468 | $5,388 | $1,920 apart |
Found publishes no rate for 3-month term, 6-month term, 12-month term; LillyDirect (Zepbound) publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $3,468 on Found and $5,188 on LillyDirect (Zepbound) — $1,720 apart, and a different gap from the $1,920 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 68.7 for Found and 46.3 for LillyDirect (Zepbound), against a tirzepatide category floor of $169. Found leads by 22.4 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Found | 40.9 | 12.8 | 10 | 5 | 68.7 |
| LillyDirect (Zepbound) | 26.4 | 15.0 | 0 | 5 | 46.3 |
Where the two programs differ
All-in monthly
Found is cheaper month to month — $289 against $449, a gap of $160 every month, or $1,920 across a year if both rates hold.
Cancellation terms
Cancellation differs: Found states Per plan terms, while LillyDirect (Zepbound) states No subscription lock. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Found asks for Program-based; LillyDirect (Zepbound) asks for None; Journey Program pricing requires refill within 45 days on 7.5 mg+. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Found charges one price at every dose; LillyDirect (Zepbound) prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Found's figure is provider-stated and LillyDirect (Zepbound)'s is verified. LillyDirect (Zepbound) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $3,468 for Found and $5,388 for LillyDirect (Zepbound). Found is lower by $1,920 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Found Official site
Found layers behavior-change coaching over medication access; compounded pricing lands at $289/month for tirzepatide and $289 at semaglutide maintenance (from a $169 start).
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — joinfound.com pricing capture 2026-08-05
Watch: Program bundles differ; confirm which plan a quoted price belongs to before comparing.
LillyDirect (Zepbound) Official site
The manufacturer's own cash channel for FDA-approved Zepbound single-dose vials: $299/month at 2.5 mg, $399 at 5 mg, and $449 for every dose from 7.5 to 15 mg through the Self Pay Journey Program — provided each refill lands within 45 days of the last, otherwise that refill reverts to $599–$1,049 by dose. This is the cheapest FDA-approved tirzepatide in the country and the benchmark every compounded price should be judged against.
It names its compounding pharmacy — Eli Lilly self-pay pharmacy (GiftHealth), recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; Journey Program pricing requires refill within 45 days on 7.5 mg+; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — Lilly investor announcement Dec 1, 2025 + LillyDirect program pages; corroborated by drugs.com pricing review updated Jun 12, 2026
Watch: The 45-day refill window is the whole game: one late refill at 10 mg costs $699 instead of $449.
Which molecules each one carries
Found carries tirzepatide at $289 a month and semaglutide at $289 a month.
LillyDirect (Zepbound) carries tirzepatide at $449 a month; does not offer semaglutide.
Comparable only on tirzepatide: they do not both publish a rankable semaglutide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Found does not publish
- no published twelve-month tirzepatide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
- no specific cancellation or refund terms
LillyDirect (Zepbound) does not publish
- no published twelve-month tirzepatide rate
Ask Found and LillyDirect (Zepbound) for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Found Official site wins this matchup. If you expect to titrate to the top of the ladder, found's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, lillydirect (zepbound)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Found's tirzepatide price is provider-stated as of 2026-08-05; LillyDirect (Zepbound)'s is verified as of 2026-08-11.
Questions
Is Found or LillyDirect (Zepbound) cheaper for tirzepatide?
Found is cheaper on all-in monthly cost at 10 mg/week: $289 against $449, a difference of $160 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Found versus LillyDirect (Zepbound)?
Found works out to $3,468 across twelve months and LillyDirect (Zepbound) to $5,388, on the plan terms each publishes.
Does Found or LillyDirect (Zepbound) raise the price as the dose goes up?
Found: no, it charges one flat rate at every dose. LillyDirect (Zepbound): yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Found and LillyDirect (Zepbound) differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Found and LillyDirect (Zepbound) names its pharmacy?
LillyDirect (Zepbound) does — Eli Lilly self-pay pharmacy (GiftHealth). Found does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.
How well evidenced are the Found and LillyDirect (Zepbound) prices?
Found's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. LillyDirect (Zepbound)'s is verified, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Found official site · LillyDirect (Zepbound) official site. Compounded tirzepatide and semaglutide are not FDA-approved products.